Histocell Overview

  • Founded
  • 2005
  • Status
  • Acquired/​Merged
  • Employees
  • 24
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $1.86M
Latest Deal Amount
  • Investors
  • 8

Histocell General Information


Developer of cell therapies designed to develop tissue engineering products, dermo-cosmetics, cell therapy medicaments, and novel medical devices for regenerative medicine. The company's cell therapies are used to conduct cell therapy-based clinical trials, with a therapeutic approach focus on the control of oxidative stress, enabling institutions to avail on-GMP cell production services.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Devices and Supplies
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • Parque Tecnológico 801A, 2º
  • 48160 Derio
  • Spain
+34 946 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Histocell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 17-Sep-2018 $1.86M 000.00 Completed Profitable
8. Later Stage VC 31-Dec-2017 00.000 0000 000.00 Completed Profitable
7. Grant 12-Dec-2016 000.00 000.00 Completed Profitable
6. Later Stage VC 30-Sep-2016 00.000 000.00 0000 Completed Profitable
5. Later Stage VC 01-Jan-2012 00.000 000 Completed Profitable
4. Debt - General 01-Dec-2011 00000 00.000 Completed Generating Revenue
3. Early Stage VC 15-Dec-2009 00.000 00.000 Completed Generating Revenue
2. Merger/Acquisition 01-Jan-2006 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Histocell’s complete valuation and funding history, request access »

Histocell Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 000.000000 0000.00 0000.00 00 0000.00 0.000
To view Histocell’s complete cap table history, request access »

Histocell Executive Team (3)

Name Title Board Seat Contact Info
Begoña Castro Co-Founder, Chief Scientific Officer & Scientific Director
Elia Fernández Valcázar Head of Marketing and Communication
Julio Font Co-Founder, Director General & Chief Executive Officer
To view Histocell’s complete executive team members history, request access »

Histocell Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial